Miller (MLR) Q3 2026 Earnings Call Transcript
Source: The Motley Fool
Miller Industries’ Q3 2026 revenue rose 18.8% year over year to $212.2 million, while net income increased to $6.1 million from $3.1 million and diluted EPS reached $0.53 from $0.27; EPS included an approximately $0.09 positive impact from non-cash Omars-related items. The company reaffirmed full-year revenue guidance of $850 million to $900 million and EPS in line with 2025, while raising expected 2026 gross margin to approximately 14%. Cash was $60.4 million at quarter-end, debt had fallen about $30 million since year-start, and Q3 shareholder returns included $2.7 million in repurchases and a $0.21-per-share dividend. Management cited manageable retail-demand pressure from elevated diesel prices and lower consumer confidence, alongside more than $200 million in military commitments and planned capacity investments.
Analysis
The headline growth rate is a weak basis for extrapolating demand: distributor inventory normalization and delayed chassis deliveries can pull revenue between quarters without changing end-customer demand. October’s stronger supplier activity supports a Q4 catch-up, but it also makes the next comparison harder. The more important test is whether orders and production sustain management’s roughly $250 million quarterly run rate into 2027.
Earnings quality is less robust than reported EPS growth implies: the quarter included a $0.09-per-share noncash benefit, while full-year EPS is still expected only to match 2025. Margin guidance near 14% benefits from lower chassis mix; a return to historical mix could remove that support even if revenue grows. Elevated diesel and weaker consumer confidence are near-term demand risks, while chassis availability is a separate supply-side swing factor.
The military backlog and new rotator support a longer-duration growth case, but are not near-term earnings catalysts: most military revenue is expected in 2028–29, and M65 sales are not expected before the second half of 2027. The capacity build can enable that growth, but creates execution and capital-allocation risk before incremental output arrives. The contrarian angle: investors may overread the backlog and facility expansion as imminent growth; alternatively, a clean Q4 chassis recovery could make current caution too pessimistic. Verify order conversion, project cost/timing, and normalized EPS before assigning a structural premium.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.42
Ticker Sentiment
Key Decisions for Investors
- Do not chase a post-call rally on revenue or EPS growth alone. Reassess after Q4 results: look for actual chassis catch-up, continued order intake, and evidence that the approximately $250 million quarterly production pace carries into 2027.
- Keep MLR on a watchlist rather than initiating a large directional position now. A staged long becomes more attractive if orders and production confirm the run rate without margin slippage; the thesis is weakened by a guidance cut, persistent supplier constraints, or gross margin falling below the approximately 14% outlook.
- Treat military commitments and the M65 launch as 2027–29 optionality, not a near-term earnings estimate. Track award-to-production conversion and M65 orders after 2027 chassis pricing is available; delay or weak order conversion would undermine the growth case.
- Monitor the Ooltewah project for cost overruns or schedule slippage and compare planned investment with operating cash generation and debt. If capacity spending crowds out balance-sheet flexibility or returns, the expansion could offset the strategic upside.
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- Shield AI To Hit $28.8 Billion Value With $5.3 Billion Radar Acquisition
- We're raising our price target on Cardinal Health after another stellar quarter of profits
- Anthropic faces valuation pushback on $1.5T IPO following market rout, WSJ reports
- Costco is taking aim at its May record high — how it got here and where's it going